| __timestamp | CRISPR Therapeutics AG | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 5280000 |
| Thursday, January 1, 2015 | 12573000 | 7148000 |
| Friday, January 1, 2016 | 42238000 | 19594000 |
| Sunday, January 1, 2017 | 69800000 | 22894000 |
| Monday, January 1, 2018 | 113773000 | 50337000 |
| Tuesday, January 1, 2019 | 179362000 | 109450000 |
| Wednesday, January 1, 2020 | 266946000 | 90450000 |
| Friday, January 1, 2021 | 438633000 | 104128000 |
| Saturday, January 1, 2022 | 461645000 | 108630000 |
| Sunday, January 1, 2023 | 387332000 | 134951000 |
| Monday, January 1, 2024 | 320653000 |
In pursuit of knowledge
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
Since 2014, CRISPR Therapeutics AG has consistently increased its R&D expenses, peaking in 2022 with a 30-fold increase from its initial spending. This upward trajectory underscores the company's dedication to advancing gene-editing technologies.
Rhythm Pharmaceuticals, Inc. has also shown a significant rise in R&D spending, with a 25-fold increase by 2023. This strategic investment reflects their focus on developing treatments for rare genetic disorders.
Both companies exemplify the biotech sector's relentless pursuit of innovation, with R&D spending as a key driver of their groundbreaking advancements.
R&D Insights: How Biogen Inc. and CRISPR Therapeutics AG Allocate Funds
United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Incyte Corporation vs CRISPR Therapeutics AG
R&D Insights: How Lantheus Holdings, Inc. and CRISPR Therapeutics AG Allocate Funds
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: CymaBay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: CRISPR Therapeutics AG vs Dynavax Technologies Corporation
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Rhythm Pharmaceuticals, Inc. and Galapagos NV